跳至主要内容
临床试验/ISRCTN83382238
ISRCTN83382238已完成未知

Does focused extracorporeal shockwave therapy improve greater trochanteric pain syndrome compared to an ultrasound guided steroid injection?

The Orthopaedic Institute0 个研究点目标入组 104 人开始时间: 2018年11月29日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
104

研究概览

简要总结

2019 Abstract results in https://online.boneandjoint.org.uk/doi/abs/10.1302/1358-992X.2019.6.015 results presented at the British Hip Society (BHS) Meeting (added 24/01/2020) 2021 Results article in https://doi.org/10.1177/11207000211060396 (added 16/08/2022)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • A patient is eligible for the trial if the patient:
  • 1. Is aged 18+ years
  • 2. Has symptoms consistent with GTPS for at least 6 months
  • 3. Failed conservative management in any other care setting
  • 4. Patient is willing and able to provide written informed consent

排除标准

  • A patient is ineligible for the trial if the patient:
  • 1. Has hip joint osteoarthritis requiring treatment on a plain radiograph
  • 2. Had surgical treatment specifically targeted at GTPS within last 6 months e.g. bursectomy/ITB lengthening
  • 3. Has ipsilateral Total Hip Replacement. (patient will not be able to undergo corticosteroid injection in clinic setting)
  • 4. Has contraindictions to ESWT treatment; pregnancy, anticoagulant therapy, advanced peripheral neuropathy, local infection, malignancy, unresolved fractures.
  • 5. Has a previous history of complications with ESWT
  • 6. Has a recent history of acute hip trauma
  • 7. Has a recent history of acute sciatica
  • 8. Is not able to attend or comply with treatment or follow-up scheduling
  • 9. Participates in any other clinical trial

研究者

发起方
The Orthopaedic Institute

相似试验